In the present study, we demonstrated that the ECM component TGFBI plays a role in HFD-induced obesity and improves several physiological conditions, such as glucose/insulin resistance, adipose expansion, liver steatosis, and adipocyte differentiation. This evidence concerns the gene TGFBI and Insulin resistance.